ReviR Therapeutics
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $30M
Investors
- 6
About ReviR Therapeutics
Based in Shenzhen, China, and established in 2021, ReviR Therapeutics is a research and development of a new drug company that focuses on target RNA small molecule drugs field. The company has an additional office in Silicon Valley. The company's core team members are from medical corporations, such as Gilead Sciences, AbbVie, Invitae, who engaged in drug discovery, computational chemistry, and computational biology for nearly 20 years. The co-founder as well as the CEO, Peng Yue, was a director of Computational Biology at AbbVie/Stemcentrx. ReviR Therapeutics established voyageR™ AI platform that developed target small molecule drugs to treat tumour, rare diseases. The platform takes the technologies of artificial intelligence algorithms and genes sequencing to analyse structure of RNA. The drugs can be used to treat tumours and other rare diseases. The company generates revenue by developing and providing targeted RNA small molecule drugs.drug development platform VoyageR, and advance the preclinical and clinical development of existing pipelines related to neurological diseases such as Huntington's disease (HD) and amyotrophic lateral sclerosis (ALS).
Who invested in ReviR Therapeutics
6 investors across 2 rounds
See all investors in ReviR Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ReviR Therapeutics
Who invested in ReviR Therapeutics?
ReviR Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ReviR Therapeutics raised?
ReviR Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ReviR Therapeutics last raise money?
ReviR Therapeutics's most recent round on record is a Series A, in Jul 2024.
What does ReviR Therapeutics do?
Based in Shenzhen, China, and established in 2021, ReviR Therapeutics is a research and development of a new drug company that focuses on target RNA small molecule drugs field.
Where is ReviR Therapeutics headquartered?
ReviR Therapeutics is headquartered in South San Francisco, US.
Which VCs invest in companies like ReviR Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ReviR Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ReviR Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.